Tech Launch Arizona has helped license and commercialize a method for growing vascularized human tissue, which can be used for research, pharmaceutical and therapeutic applications. The exclusive license agreement is between The University of Arizona and Angiomics of Louisville, Kentucky.
The technology was developed in the 1990s when Stuart Williams was in the Department of Surgery at the UA College of Medicine and founded the UA’s biomedical engineering program while James Hoying earned his doctorate at the university and became an associate professor in its Arizona Research Laboratories. Hoying is CEO of Angiomics.
The company is developing off-the-shelf and customized vascularizing solutions for human 3-D tissue and disease models to help advance tissue biology and accelerate drug discovery efforts. One application is development of treatments for cardiovascular disease.